DAVID G JOHNSON to Mice
This is a "connection" page, showing publications DAVID G JOHNSON has written about Mice.
Connection Strength
0.358
-
Kinesin-1 Proteins KIF5A, -5B, and -5C Promote Anterograde Transport of Herpes Simplex Virus Enveloped Virions in Axons. J Virol. 2018 10 15; 92(20).
Score: 0.038
-
E2F1 promotes the recruitment of DNA repair factors to sites of DNA double-strand breaks. Cell Cycle. 2011 Apr 15; 10(8):1287-94.
Score: 0.022
-
Adenovirus vectors expressing hantavirus proteins protect hamsters against lethal challenge with andes virus. J Virol. 2009 Jul; 83(14):7285-95.
Score: 0.020
-
Transgenic expression of E2F3a causes DNA damage leading to ATM-dependent apoptosis. Oncogene. 2008 Aug 21; 27(36):4954-61.
Score: 0.018
-
Silencing herpes simplex virus with a vaginal microbicide. N Engl J Med. 2006 Mar 02; 354(9):970-1.
Score: 0.016
-
E2F1 suppresses skin carcinogenesis via the ARF-p53 pathway. Oncogene. 2006 Feb 09; 25(6):867-76.
Score: 0.016
-
ATM promotes apoptosis and suppresses tumorigenesis in response to Myc. Proc Natl Acad Sci U S A. 2006 Jan 31; 103(5):1446-51.
Score: 0.016
-
The extracellular domain of herpes simplex virus gE is indispensable for efficient cell-to-cell spread: evidence for gE/gI receptors. J Virol. 2005 Sep; 79(18):11990-2001.
Score: 0.015
-
Herpes keratitis in the absence of anterograde transport of virus from sensory ganglia to the cornea. Proc Natl Acad Sci U S A. 2005 Aug 09; 102(32):11462-7.
Score: 0.015
-
Inactivation of E2f1 enhances tumorigenesis in a Myc transgenic model. Cancer Res. 2002 Jun 01; 62(11):3276-81.
Score: 0.012
-
ARF differentially modulates apoptosis induced by E2F1 and Myc. Mol Cell Biol. 2002 Mar; 22(5):1360-8.
Score: 0.012
-
Myc lacks E2F1's ability to suppress skin carcinogenesis. Oncogene. 2001 Aug 30; 20(38):5341-9.
Score: 0.012
-
E2F4 and E2F1 have similar proliferative properties but different apoptotic and oncogenic properties in vivo. Mol Cell Biol. 2000 May; 20(10):3417-24.
Score: 0.010
-
The paradox of E2F1: oncogene and tumor suppressor gene. Mol Carcinog. 2000 Mar; 27(3):151-7.
Score: 0.010
-
Regulation of BRCA1 expression by the Rb-E2F pathway. J Biol Chem. 2000 Feb 11; 275(6):4532-6.
Score: 0.010
-
E2F1 has both oncogenic and tumor-suppressive properties in a transgenic model. Mol Cell Biol. 1999 Sep; 19(9):6408-14.
Score: 0.010
-
Increased E2F1 activity induces skin tumors in mice heterozygous and nullizygous for p53. Proc Natl Acad Sci U S A. 1998 Jul 21; 95(15):8858-63.
Score: 0.009
-
Role of E2F in cell cycle control and cancer. Front Biosci. 1998 Apr 27; 3:d447-8.
Score: 0.009
-
Deregulated expression of E2F1 induces hyperplasia and cooperates with ras in skin tumor development. Oncogene. 1998 Mar 12; 16(10):1267-76.
Score: 0.009
-
FAAH genetic variation enhances fronto-amygdala function in mouse and human. Nat Commun. 2015 Mar 03; 6:6395.
Score: 0.007
-
Oncogenic capacity of the E2F1 gene. Proc Natl Acad Sci U S A. 1994 Dec 20; 91(26):12823-7.
Score: 0.007
-
Slug expression in mouse skin and skin tumors is not regulated by p53. J Invest Dermatol. 2014 Feb; 134(2):566-568.
Score: 0.007
-
Altered fear learning across development in both mouse and human. Proc Natl Acad Sci U S A. 2012 Oct 02; 109(40):16318-23.
Score: 0.006
-
A high-frequency regulatory polymorphism in the p53 pathway accelerates tumor development. Cancer Cell. 2010 Sep 14; 18(3):220-30.
Score: 0.005
-
Enhanced skin carcinogenesis and lack of thymus hyperplasia in transgenic mice expressing human cyclin D1b (CCND1b). Mol Carcinog. 2009 Jun; 48(6):508-16.
Score: 0.005
-
Overexpression of the low molecular weight cyclin E in transgenic mice induces metastatic mammary carcinomas through the disruption of the ARF-p53 pathway. Cancer Res. 2007 Aug 01; 67(15):7212-22.
Score: 0.004
-
Transgenic E2F1 expression in the mouse brain induces a human-like bimodal pattern of tumors. Cancer Res. 2007 May 01; 67(9):4005-9.
Score: 0.004
-
Expression of transcription factor E2F1 and telomerase in glioblastomas: mechanistic linkage and prognostic significance. J Natl Cancer Inst. 2005 Nov 02; 97(21):1589-600.
Score: 0.004
-
SAGE profiling of UV-induced mouse skin squamous cell carcinomas, comparison with acute UV irradiation effects. Mol Carcinog. 2005 Jan; 42(1):40-52.
Score: 0.004
-
Lack of cyclin-dependent kinase 4 inhibits c-myc tumorigenic activities in epithelial tissues. Mol Cell Biol. 2004 Sep; 24(17):7538-47.
Score: 0.004
-
Inactivating E2f1 reverts apoptosis resistance and cancer sensitivity in Trp53-deficient mice. Nat Cell Biol. 2003 Jul; 5(7):655-60.
Score: 0.003
-
Human cytomegalovirus glycoprotein UL16 causes intracellular sequestration of NKG2D ligands, protecting against natural killer cell cytotoxicity. J Exp Med. 2003 Jun 02; 197(11):1427-39.
Score: 0.003
-
Molecular cloning and characterization of a novel mouse epidermal differentiation gene and its promoter. Genomics. 2001 May 01; 73(3):284-90.
Score: 0.003
-
E2F-1 gene transfer enhances invasiveness of human head and neck carcinoma cell lines. Cancer Res. 2000 Nov 01; 60(21):5972-6.
Score: 0.003
-
Rapid analysis of gene expression (RAGE) facilitates universal expression profiling. Nucleic Acids Res. 1999 Dec 01; 27(23):4609-18.
Score: 0.003
-
Conditional transformation of rat embryo fibroblast cells by a cyclin D1-cdk4 fusion gene. Oncogene. 1999 Nov 04; 18(46):6343-56.
Score: 0.003
-
Deregulated expression of cell-cycle proteins during premalignant progression in SENCAR mouse skin. Oncogene. 1998 Oct 29; 17(17):2251-8.
Score: 0.002
-
Synchronized proliferation induced by 12-O-tetradecanoylphorbol-13-acetate treatment of mouse skin: an in vivo model for cell cycle regulation. Cell Growth Differ. 1998 Jan; 9(1):31-9.
Score: 0.002